Silo Pharma, Inc.
SILO
$0.45
$0.00-0.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.76% | -34.18% | -39.27% | -28.54% | -18.70% |
| Total Depreciation and Amortization | 83.87% | 274.19% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67,081.82% | 754.33% | -85.94% | -101.15% | -99.38% |
| Change in Net Operating Assets | -314.61% | -175.83% | -139.04% | -124.17% | 84.33% |
| Cash from Operations | -21.58% | -25.40% | -46.11% | -37.57% | -18.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.87% | -79.30% | -82.47% | -10.78% | 123.48% |
| Cash from Investing | -33.87% | -79.30% | -82.47% | -10.78% | 123.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 42.33% | -20.08% | 129.23% | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 90.16% | 63.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.93% | -10.45% | 230.65% | 672.30% | 788.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.97% | -120.24% | -103.97% | 123.46% | 104.86% |